Antidepressant Medications: Biology, Exposure
& Response
(AMBER)
The AMBER study (Antidepressant Medications: Biology, Exposure & Response) is a Wellcome-funded Mental Health Award that aims to identify the causal determinants of antidepressant response (2023-2028).
Our research is carried out in collaboration with people who have lived experience of depression and antidepressant treatment. This partnership aims to increase trust, ensure the relevance and significance of our research, and improve the dissemination and impact of the research findings.
King’s investigators, Cathryn Lewis and Oliver Pain, work in collaboration with researchers at the University of Edinburgh (Andrew McIntosh, Heather Whalley, Sue Fletcher-Watson) and the University of Queensland (Sonia Shah, Quan Nguyen, Naomi Wray) to achieve this ambitious project.
Our work so far
To date, we have published several papers/preprints:
For details on AMBER project, please visit our King’s website here.
We welcome new collaborators with relevant data sources on any aspect of antidepressants: email cathryn.lewis@kcl.ac.uk.
Please post questions as an issue on the T-Rx GitHub repo here.
The T-Rx package is currently under beta testing. Most functions should have adequate documentation on possible errors.
Please kindly reach out to Chris Lo (chris.lowh@kcl.ac.uk) for feedback on documentation.